iShares US Healthcare ETF (IYH)
268.83
-2.07 (-0.76%)
USD |
Jun 11, 20:00
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.43% | -0.07% | 2.609B | 27680.00 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 1.06% | 5.00% | -307.47M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to track the investment results of the Dow Jones U.S. Health Care Index composed of U.S. equities in the healthcare sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | iShares |
| Prospectus Benchmark Index | |
| DJ US Health Care TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Greg Savage | 13.42 yrs |
| Jennifer Hsui | 8.75 yrs |
| Alan Mason | 5.13 yrs |
| Amy Whitelaw | 2.75 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
97
-307.47M
-4.628B
Category Low
7.419B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2021
Performance Versus Category
As of June 11, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of June 11, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Johnson & Johnson | 8.50% | 164.96 | -1.27% |
| UnitedHealth Group Inc | 7.40% | 397.89 | -0.90% |
| Pfizer Inc | 4.33% | 40.15 | -1.30% |
| AbbVie Inc | 3.93% | 115.42 | -0.71% |
| Abbott Laboratories | 3.77% | 109.91 | -0.22% |
| Merck & Co Inc | 3.66% | 76.27 | 0.17% |
| Eli Lilly and Co | 3.51% | 224.09 | -4.05% |
| Thermo Fisher Scientific Inc | 3.45% | 465.15 | 0.05% |
| Medtronic PLC | 3.24% | 123.78 | -0.77% |
| Danaher Corp | 2.98% | 247.02 | 0.31% |
News
Headline
Wire
Time (ET)
MT Newswires
06/11 08:42
MT Newswires
06/10 08:27
MT Newswires
06/09 08:20
MT Newswires
06/08 07:29
MT Newswires
06/07 09:08
MT Newswires
06/03 08:02
MT Newswires
06/02 08:45
MT Newswires
06/01 07:58
Basic Info
| Investment Strategy | |
| The investment seeks to track the investment results of the Dow Jones U.S. Health Care Index composed of U.S. equities in the healthcare sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | iShares |
| Prospectus Benchmark Index | |
| DJ US Health Care TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Greg Savage | 13.42 yrs |
| Jennifer Hsui | 8.75 yrs |
| Alan Mason | 5.13 yrs |
| Amy Whitelaw | 2.75 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (6-11-21) | 1.06% |
| 30-Day SEC Yield (3-31-20) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 27.47 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of June 09, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 6/12/2000 |
| Last Annual Report Date | 4/30/2020 |
| Last Prospectus Date | 9/1/2020 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
MT Newswires
06/11 08:42
MT Newswires
06/10 08:27
MT Newswires
06/09 08:20
MT Newswires
06/08 07:29
MT Newswires
06/07 09:08
MT Newswires
06/03 08:02
MT Newswires
06/02 08:45
MT Newswires
06/01 07:58